Clinical Manual of Child and Adolescent Psychopharmacology

 

Updated to include a succinct yet thorough review of the most recent evidence-based information and data-driven best treatment practices in child and adolescent psychiatry, this fourth edition of the Clinical Manual of Child and Adolescent Psychopharmacology not only examines the evidence for treating mental health disorders in younger patients but also illuminates how clinical trials of various methodologies can inform different aspects of clinical practice.

Organized by DSM-5-TR diagnosis rather than drug class, this clinically accessible volume offers an exhaustive analysis of the use of psychotropic agents in disorders that include

• Attention-deficit/hyperactivity disorder• Depressive disorders• Autism spectrum disorder• Early schizophrenia and psychotic illnesses• Eating disorders

Comprehensive medication tables allow for easy reference of dosing, side effects, and tips for management.

Additionally, key points at the conclusion of each chapter summarize essential information for treating clinicians.

With a depth of information unmatched by any other guide, this new edition of the Clinical Manual of Child and Adolescent Psychopharmacology is an indispensable desktop reference for clinicians working with young patients.

 

Table of Contents:

 

1 Developmental Aspects of Pediatric Psychopharmacology

Pharmacokinetics and Metabolism

Pharmacodynamics

Efficacy

Safety

Ethical Aspects

Regulatory Aspects

Conclusion

2 Attention-Deficit/Hyperactivity Disorder

Diagnosis

Treatment

Role of Nonstimulant Medication in the Treatment of ADHD

Monitoring Treatment

Choice of Medication

Conclusion

3 Disruptive Behavior Disorders and Aggression

Epidemiology

Differential Diagnosis

Course and Outcome

Rationale and Justification for Psychopharmacological Treatment

Review of Treatment Studies

Safety Issues

Practical Management Strategies

Conclusion

4 Anxiety Disorders

Epidemiology

Course and Outcome

Rationale and Justification for Psychopharmacological Treatment

Medications for Pediatric Anxiety Disorders: Review of Treatment Studies

Safety Issues

Practical Management Strategies: Treatment Approaches, Algorithms, and Guidelines

Conclusion

5 Major Depressive Disorder

Assessment of Treatment Response

Treatment Phases

Treatment of MDD With Selective Serotonin Reuptake Inhibitors and Other Novel Antidepressants

Treatment of Major Depressive Disorder Subtypes and Bipolar Depression

Treatment of Comorbid Conditions and Suicidality

Continuation Therapy

Maintenance Therapy

6 Bipolar Disorders

Treatment of Acute Manic or Mixed States

Maintenance Therapy

Treatment of Pediatric Bipolar Depression

Combination Pharmacotherapy

Conclusion

7 Autism Spectrum Disorder

Atypical Antipsychotics

Serotonin Reuptake Inhibitors

Psychostimulants

Other Drug Treatments for ADHD

Mood Stabilizers

Cholinesterase Inhibitors

Glutamatergic Agents

Other Compounds

Safety Issues

Practical Management Strategies

8 Tic Disorders

Epidemiology

Diagnosis and Assessment

Treatment of Tics in Children With Tourette’s Disorder

Comorbid Illnesses With Tics or Tourette’s Disorder

Conclusion

9 Early-Onset Schizophrenia and Psychotic Illnesses

History and Classification of Psychosis in Children

Epidemiology

Course and Outcome

Rationale for Psychopharmacological Treatment

Pharmacotherapy

Treatment of Comorbid Conditions

Treatment of Side Effects

Early Intervention Studies

Conclusion

10 Eating Disorders

Anorexia Nervosa

Bulimia Nervosa

Binge-Eating Disorder

Avoidant/Restrictive Food Intake Disorder

Pica

Rumination Disorder

Conclusion

Index